Merck begins investigation into its handling of Vioxx
Directors at Merck are investigating the company’s actions prior to its voluntary withdrawal of Vioxx from the market in September.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.